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from solid meals because of many oral ulcers 
in her mouth but she could still eat liquids. She 
also had chest pain associated with breath and 
dyspnea. She admitted a 20 kg weight loss and 
the occasional dizziness. She denied chronic 
cough with hemoptisis or bleeding per rectum. 
She reported oral ulcer exacerbation for the past 2 
months, falling hair with alopecia for the past 10 
years, chronic fatigue for the past 3 years, and also 
intermittent fever and amenorrhea for the past 2 
months. She also complained of photosensitivity 
associated with ultraviolet light. 
She was referred from another hospital with 
diagnoses of suspected pulmonary tuberculosis, 
anemia and fever, and lymphadenitis axillaries 
caused by tuberculosis in 1997.
The results of physical examination were 
as follows. She looked older than her stated 
age, emaciated and lethargic, mental state was 
somnolent, blood pressure was 104/60 mmHg, 
pulse rate was 120 times/minute, respiratory rate 
was 32-36 times/minute, and body temperature 
was 38.8oC. She had no lymphadenopathy. On 
head examination, there were alopecia areata 
(Lupus hair), pale conjunctiva, malar rash, and 
oral ulcer. There was no abnormality detected in 
ears, nose, and throat. On lung examination, the 
main respiratory sound was vesicular breathing 
in both lungs. there were rales in right and left 
thorax, decreased breath sounds, pleural friction 
rub in left thoracic, and there was no audible 
murmur or pericardial friction rub. The abdomen 
was supple on palpation, but we found the 
chessboard phenomenon and tenderness. The liver 
and spleen were not palpable and intestinal sound 
was normal on auscultation. On the extremities, 
there was vasculitis in palm and sole. There was 
not any arthritis or oedema.
Systemic lupus erythematosus (SLE) patients 
have multi-organ involvement related to their 
chronic infl ammatory, autoimmune disease. 
Calcinosis can be clinical manifestations of SLE. 
Tissue calcinosis is reported in approximately 
17% patients and myocarditis in 20-55% patients. 
Thus, both manifestations are not unusual in SLE. 
Tachypnea, tachycardia, pericardial effusion, and 
wheezing are often present and can be misleading 
in SLE patient.1,2
Calcinosis is less common in SLE, sometimes 
it is found as an incidental radiological fi nding. 
Calcifi cation in SLE maybe periarticular, within 
joints or muscles, or in the subcutis (calcinosis 
universalis).1 Calcinosis is classifi ed into four 
subsets: dystrophic, metastatic, idiopathic, or 
calciphylaxis/iatrogenic. When calcinosis cutis is 
isolated to a small area in extremities and joints, 
it is called calcinosis circumscripta; whereas its 
diffuse form, refers to calcinosis universalis, 
affects subcutaneous and fi brous structures of 
muscles and tendons. The pathophysiology of this 
condition is unknown and no effective therapy is 
currently available.3,4,5 
Systemic lupus erythematosus can involve 
the myocardium, pericardium, cardiac valves, 
and coronary arteries. Myocarditis in SLE is not 
likely to produce major regional wall motion 
abnormalities but may contribute to global left 
ventricular dysfunction.7,8
We report a young woman with SLE who 
developed calcinosis and myocarditis.
CASE ILLUSTRATION
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A 23-year-old female presented with a history of 
severe fatigue, dyspnea, and dysphagia. Fatigue 
had developed over the past 3 months and had 
gotten worse upon exertion. She had dysphagia 
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Figure 1 A. Lupus hair 
and photosensitivity.
B & C. Vasculitis of 
palm and soles
Case Report
37Indonesian Journal of Rheumatology 2010; Vol 02
Laboratory studies disclosed the following values: 
haemoglobin 8.6 gr/dL, haematocrit 25%, leukocyte count 
was 13.200-30.300/mm3, platelet count was 170.000/mm3, 
erythrocyte sedimentation rate 120 / 138, blood glucose leves 
was 74/104mg/dL, blood urea nitrogen level was 45mg/dL, 
serum creatinine level was 1.7 mg/dL, Na level was 116 mEq/
L, K level was 3.7 mEq/L, SGOT level was 126 U/L, SGPT 
level was 41 U/L. The urinalysis showed proteinuria (++), 
erythrocyte (++++), leucocyte 5-11/high power fi eld.
The fi rst chest x-ray showed calcifi cation but no 
cardiomegaly. Electrocardiogram showed sinus tachycardia 
with 120 times/minute. An ultrasonography of the abdomen 
showed mild hepatomegaly with ascites, there was no 
enlargement of paraaorta or parailiaca lymph nodes, bilateral 
pleural effusions, no abnormality in spleen, pancreas, kidney 
and ureter, and there was a cystitis.
She was admitted to the hospital with working diagnoses 
of pulmonary tuberculosis and abdominal tuberculosis, 
suspected SLE, and dehydration caused by low intake.
The patient was getting worst on the third day of 
hospitalization. The mental state become delirium, loss 
of consciousness, respiratory distress, arythmias, bilateral 
pleural effusions, suspected pericardial effusion, and focal 
neurological defi cit. The working diagnoses were changed 
into suspected hospital acquired pneumonia, pulmonary 
and peritonitis tuberculosis, suspected SLE, unconciousness 
caused by meningitis tuberculosis with differential diagnoses 
of hyponatremia and neuropsychiatric lupus. She was 
subsequently given rehydration with normal saline and 
intravenous antibiotic. Afterwards the patient was consulted 
to rheumatologist.
The fi nal diagnoses were established SLE with vasculitis, 
calcinosis and myocarditis based on the results of blood test 
of positive antinuclear antibody test with homogenous pattern 
and positive anti-double-stranded DNA (anti-ds DNA), 936.6 
IU/ml (the signifi cance was higher when the anti-ds DNA 
antibody level was >300 IU/ml) by ELISA method.
The patient was treated with broadspectrum antibiotics 
(2 gram ceftriaxone, single dose/day) and pulse dose of 1000 
mg methyl prednisolone on the last day, but did not give any 
response. Her condition was deteriorated with infection and 
complication of the main organ (carditis).  The patient had full 
arrest and was not able to be resuscitated.  She died on the fi fth 
day of hospitalization, before get the MRI, CT scan, and serial 
hemoculture examination, and also an adequate therapy.
 
Figure 2  A. X-Ray on the fi rst day of admission. B. X-Ray on the fourth 
day of admission
DISCUSSION
In this case we discussed about a young woman with SLE 
who developed calcinosis and myocarditis. Tissue calcinosis 
is reported in approximately 17% and myocarditis in 20-
55% of patients with SLE. Thus, both manifestations are not 
unusual in SLE. Calciphylaxis and calcinosis can both cause 
severe morbidity and mortality in patients with SLE.1,2 It was 
hypothesized that in calciphylaxis and calcinosis, ongoing 
infl ammatory activity contributes to the calcium deposition 
in the media of small arteries, as well as perivascular and 
periarticular tissues. The neuropsychiatric lupus with wide 
variety of conditions has been reported in association with 
SLE.  Note that true cerebral vasculitis has been documented 
in SLE, but it is very uncommon. An example of an uncommon 
condition associated with SLE is severe cerebral calcinosis. 
Calcifi cation in the basal ganglia has been reported in SLE at 
a higher incidence than in the general population, and in fewer 
cases, the cerebral cortex, cerebral white matter, thalamus, 
cerebellum, and brain stem are involved.3,4,5
Cardiomegaly can be a result of SLE myocarditis, Libman-
Sacks endocarditis, subacute bacterial endocarditis, uremia, 
pulmonary arterial hypertension with right-sided heart failure, 
or corticosteroid-related cardiomyopathy.6,7,8 Myocarditis 
may be clinically silent in up to 50% of patients and is an 
uncommon manifestation of SLE, consisting of myositis with 
perivascular infi ltration by lymphocytes and neutrophils. 
Intimal proliferation within the smaller intramyocardial 
arteries with hyalinization has been reported. Transesophageal 
echocardiography helps defi ne wall motion abnormality. 
The newer and faster magnetic resonance imaging in cine 
acquisition mode may allow noninvasive evaluation. In 
addition, exercise electrocardiography and myocardial 
scintigraphy may help defi ne reversible ischemia, typically 
from accelerated atherosclerosis, that is amenable to surgery 
or intravascular therapy in SLE patients with symptoms of 
myocardial disease.6,7,8
  Exudative pericardial effusions and pericarditis occur 
in 17-50% of patients with SLE. Unless pericarditis is 
accompanied by effusion, echocardiography is unsensitive for 
the diagnosis. Clinical symptoms and electrocardiographic 
fi ndings may be helpful in the diagnosis of SLE pericarditis. 
Contrast-enhanced chest CT may reveal abnormal thickening 
and enhancement of the pericardium as well as a pericardial 
effusion.6-8
Patient with myocarditis may present tachypnea, 
tachycardia, hyperthermia or hypothermia, and hypotension. 
Sign of poor perfusion and heart failure such as tachycardia, 
weak pulses, decreased capillary refi ll, cool mottled 
extremities, jugular venous distention, lower extremity edema 
may also be found. Heart tones may include an S3 gallop and 
may be muffl ed if pericarditis is present. An additional sound 
can be found in lung examination. Although several types of 
dysrhythmias occur, the most common dysrhythmia is sinus 
tachycardia. A tachycardia faster than expected for the degree 
of fever (10 BPM for each degree of temperature elevation) 
may be indicative of myocarditis. Tamponade may result in 
hypotension, muffl ed heart tones, and distended neck vein 
(present in >50% of patients with tamponade). The ECG 
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shows tachycardia, low QRS voltages, fl attened or inverted T 
waves with ST-T wave changes, and prolongation of the QT 
interval. Cardiomegaly may be found on CX-Ray.6-8
Autoimmune myocarditis, a chronic stage of myocardial 
infl ammation, occurs in a small subset of patients after 
acute cardiotropic viral infection and can lead to dilated 
cardiomyopathy (DCM). The etiologies of myocarditis are 
multifactorial and genetically complex. Genetic linkage 
between susceptibility to myocarditis/DCM and the major 
histocompatibility complex (MHC) genes has been reported 
in both humans and experimentally induced mouse models. 
However, unlike other autoimmune diseases, the non-MHC 
genes seem to have greater impact than MHC genes on 
disease susceptibility. In humans, mutations/deletions in 
immunologically important genes such as CD45, and genes 
encoding cardiac proteins, have been reported in patients 
with recurrent myocarditis or DCM. Identifi cation of genetic 
polymorphisms controlling autoimmune myocarditis will 
help us understand the mechanisms underlying autoimmune 
diseases in general, thereby improving potential therapies in 
patients.7
In this case, the patient had clinical characteristic for 
myocarditis on the last day of her life. The worsening of the 
disease activities with acute chest syndrome may be associated 
with myocarditis. The clinical characteristics of acute chest 
syndrome are fever (80%), cough (62%), chest pain (44%), and 
radiographic fi ndings which developed in 2-5 days of hospital 
admission. She should have been treated for acute chest 
syndrome, including oxygen therapy if the patient is hypoxic, 
pain control to avoid splinting, fl uid therapy at maintenance 
rates (do not overload), broad spectrum antibiotic such as 
cefuroxime and macrolide, bronchodilators,  furosemide 
(no digoxin as this may increase cytokines and mortality), 
dopamin, dobutamine, and nitropruside, pulse dose steroid 
and cyclosporine, and pericardiocentesis if unstable.9 
The leukocytosis in this case should be evaluated for many 
causes, infection or other causes (dehydration, steroid induced, 
etc). In this case, the blood culture only made on the fi rst 
admission, and the result was sterile. We should have made the 
serial hemocultures to found the microorganism, analysis of 
the sputum, cultures of the sputum, etc. The result of urinalysis 
(proteinuria (++), erythrocyte (++++), leucocyte 5-11/high 
power fi eld) made the suspicion of kidney involvement came 
into view, but more information such as measurement of 24-
hours was needed. In this case we have no more data, because 
the patient died before the examination.
There are many limitation in this case: 1) Some laboratory 
fi ndings are missing: no data for serial hemocultures, 24-
hour proteinuria, and other autoantibodies (especially 
antiphospholipid), 2) The patient developed neurologic 
manifestations, but MRI or CT was not performed, and 3) We 
have no any information regarding post-mortem examination, 
because we did not do the test.
The management of SLE patients depends on the organ 
involvements, disease activity, and time of establishing the 
diagnoses. In this case, the diagnoses and the management were 
missed and delayed. We must be aware for early diagnose of 
SLE in young woman with the skin abnomalities (lupus hair, 
vasculitis, calcinosis, etc), and many organ involvement such 
as lung (pleuritic/pneumonitis), cardiac (myocarditis), kidney 
(nephritis), and neurologic manifestations, to avoid the delay 
in the adequate management. In this case, the patient should 
have been diagnosed earlier and therefore received adequate 
therapies.9
SUMMARY
Systemic lupus erythematosus is a complex autoimmune disease 
with multisystem involvement.  The patients with SLE and 
calcinosis may increase the severity of disease and can spread 
to other organs and cause other diseases such as myocarditis. 
This condition may lead to a life threatening disease and 
therefore it is crucial to receive an immunosuppressant 
therapy as soon as possible to save their lives.  We can use a 
set of recommendations for monitoring SLE patients in routine 
clinical practice. The use of a standardized core set to monitor 
SLE patients should facilitate clinical practice, as well as the 
quality control of care for SLE patients.
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